Subscalp Placement Of The LINQII Device: A First-in-human Device Feasibility Study
The purpose of this to evaluate the capability of the FDA approved Medtronic LINQ II device (implantable cardiac monitoring device) to record EEG signals when placed temporarily in the subscalp space in patients undergoing cranial neurosurgery. No disease-directed therapeutic efficacy endpoints will be studied.
Neurophysiologically Based Brain State Tracking and Modulation in Focal Epilepsy